HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jan Pohl Selected Research

Polysaccharides (Glycans)

10/2010The human host defense peptide LL-37 interacts with Neisseria meningitidis capsular polysaccharides and inhibits inflammatory mediators release.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jan Pohl Research Topics

Disease

20Infections
01/2021 - 06/2003
6Inflammation (Inflammations)
11/2022 - 11/2007
5Neoplasms (Cancer)
04/2008 - 09/2006
3Human Influenza (Influenza)
01/2020 - 01/2011
2Atherosclerosis
11/2022 - 11/2007
2Malaria
01/2021 - 10/2005
2Fibrosis (Cirrhosis)
01/2018 - 01/2015
2Carcinoma (Carcinomatosis)
01/2015 - 06/2005
2Cystic Fibrosis (Mucoviscidosis)
12/2007 - 12/2002
1COVID-19
12/2020
1Prodromal Symptoms
12/2018
1Disease Susceptibility (Diathesis)
10/2017
1Necrosis
09/2017
1Bacterial Infections (Bacterial Infection)
09/2017
1Chlamydia Infections
01/2017
1Respiratory Syncytial Virus Infections
01/2016
1Starvation
12/2015
1Fever (Fevers)
05/2015
1Cough
05/2015
1Infertility (Sterility)
01/2015
1Carcinogenesis
01/2015
1Toxocariasis
01/2015
1Septic Shock (Toxic Shock Syndrome)
06/2014
1Sepsis (Septicemia)
06/2014
1Communicable Diseases (Infectious Diseases)
01/2013
1Tuberculosis (Tuberculoses)
01/2013
1Meningococcal Infections
10/2010
1Type I Syndactyly
09/2010
1Pneumococcal Infections
08/2010
1Obesity
01/2010

Drug/Important Bio-Agent (IBA)

15Proteins (Proteins, Gene)FDA Link
01/2020 - 06/2005
13Peptides (Polypeptides)IBA
01/2020 - 11/2002
7CathelicidinsIBA
01/2020 - 10/2010
6Antiviral Agents (Antivirals)IBA
01/2020 - 10/2009
3Peptide Hydrolases (Proteases)FDA Link
11/2022 - 06/2003
3AntigensIBA
01/2021 - 11/2002
3AntibodiesIBA
01/2021 - 12/2018
3EpitopesIBA
01/2021 - 10/2005
3Antimicrobial Cationic PeptidesIBA
10/2017 - 01/2011
3ProteomeIBA
12/2015 - 12/2006
3Biomarkers (Surrogate Marker)IBA
02/2007 - 06/2005
2Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
11/2022 - 01/2010
2Immunoglobulin G (IgG)IBA
01/2021 - 12/2020
2Pharmaceutical PreparationsIBA
01/2020 - 04/2008
2Phosphotransferases (Kinase)IBA
01/2018 - 01/2017
2MicroRNAs (MicroRNA)IBA
01/2018 - 01/2015
2Colistin (Coly-Mycin)FDA Link
01/2016 - 05/2013
2Sulfhydryl Compounds (Thiols)IBA
12/2015 - 11/2007
2Amino AcidsFDA Link
12/2015 - 03/2006
2Cystine (L-Cystine)IBA
09/2010 - 01/2010
2Biological ProductsIBA
05/2007 - 10/2005
1Serine Proteases (Serine Protease)IBA
11/2022
1Kallikreins (Kallikrein)IBA
11/2022
1Apolipoproteins E (ApoE)IBA
11/2022
1Immunoglobulin IsotypesIBA
01/2021
1Messenger RNA (mRNA)IBA
01/2020
1Histones (Histone)IBA
01/2020
1TARPIBA
01/2019
1Myosin Type IIIBA
01/2019
1Connective Tissue Growth FactorIBA
01/2018
1CollagenIBA
01/2018
1DNA (Deoxyribonucleic Acid)IBA
01/2018
1Cadherins (E-Cadherin)IBA
01/2018
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2018
1Tyrosine (L-Tyrosine)FDA Link
01/2018
1OligonucleotidesIBA
01/2018
1protegrin-1IBA
09/2017
1Inositol (Myoinositol)IBA
01/2017
1eIF-2 Kinase (eIF 2 Kinase)IBA
01/2017
1Adenosine Triphosphate (ATP)IBA
01/2017
1ChemokinesIBA
01/2016
1leupeptinIBA
12/2015
1EnzymesIBA
05/2015
1CaspasesIBA
01/2015
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2015
1mouse MIRN29 microRNAIBA
01/2015
1Caspase InhibitorsIBA
01/2015
1GalactosamineIBA
06/2014
1EndotoxinsIBA
06/2014
1Interleukin-6 (Interleukin 6)IBA
06/2014
1Anti-Bacterial Agents (Antibiotics)IBA
05/2013
1Subunit VaccinesIBA
01/2013
1Glycoproteins (Glycoprotein)IBA
01/2013
1Complementary RNA (cRNA)IBA
01/2012
1InterferonsIBA
01/2012
13' Untranslated Regions (3' UTR)IBA
01/2012
1LigandsIBA
01/2012
1Complement System Proteins (Complement)IBA
01/2012
15' Untranslated Regions (5' UTR)IBA
01/2012
1Amyloid (Amyloid Fibrils)IBA
01/2011
1prostatic acid phosphataseIBA
01/2011
1DefensinsIBA
01/2011
1Antimicrobial PeptidesIBA
01/2011
1VaccinesIBA
10/2010
1Virulence Factors (Pathogenicity Factors)IBA
10/2010
1Polysaccharides (Glycans)IBA
10/2010
1DisulfidesIBA
09/2010
1Recombinant ProteinsIBA
09/2010
1MacrolidesIBA
08/2010

Therapy/Procedure

4Therapeutics
09/2017 - 04/2008